Funder
Belgian Federal Public Service of Health
Vlaamse Liga Tegen Kanker
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Biondi A, Rizzari C, Valsecchi MG, De Lorenzo P, Arico M, Basso G, Locatelli F, Lo Nigro L, De Rossi G, Masera G. Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica. 2006 Apr;91(4):534–7. Epub 2006/03/16. Cited in: Pubmed; PMID 16537119.
2. Dördelmann M, Reiter A, Borkhardt A, Ludwig W-D, Götz N, Viehmann S, Gadner H, Riehm HR, Schrappe M. Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia. Blood. 1999;94(4):1209–17. https://doi.org/10.1182/blood.V94.4.1209.
3. Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA, McGlennen R, Smith FO, Woods WG, Salzer WL, Johnstone HS, Dreyer Z, Reaman GH, Children’s OG. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children’s Oncology Group. Blood. 2006;108(2):441–51. https://doi.org/10.1182/blood-2005-07-3011.
4. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O’Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children’s Cancer Group. J Clin Oncol. 1999;17(2):445–55. https://doi.org/10.1200/JCO.1999.17.2.445.
5. Chessells JM, Harrison CJ, Watson SL, Vora AJ, Richards SM. Medical Research Council Working Party on Childhood L. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987–1999. Br J Haematol. 2002;117(2):306–14. https://doi.org/10.1046/j.1365-2141.2002.03442.x.